43 related articles for article (PubMed ID: 38709246)
1. Outer membrane vesicle-wrapped manganese nanoreactor for augmenting cancer metalloimmunotherapy through hypoxia attenuation and immune stimulation.
Luo S; Yang Y; Chen L; Kannan PR; Yang W; Zhang Y; Zhao R; Liu X; Li Y; Kong X
Acta Biomater; 2024 Jun; 181():402-414. PubMed ID: 38734282
[TBL] [Abstract][Full Text] [Related]
2. Multiple Synergistic Effects of the Microglia Membrane-Bionic Nanoplatform on Mediate Tumor Microenvironment Remodeling to Amplify Glioblastoma Immunotherapy.
Fan Q; Kuang L; Wang B; Yin Y; Dong Z; Tian N; Wang J; Yin T; Wang Y
ACS Nano; 2024 Jun; 18(22):14469-14486. PubMed ID: 38770948
[TBL] [Abstract][Full Text] [Related]
3. Immune modulation of the liver metastatic colorectal cancer microenvironment via the oral CAPOX-mediated cGAS-STING pathway.
Park SJ; Kweon S; Moyo MK; Kim HR; Choi JU; Lee NK; Maharjan R; Cho YS; Park JW; Byun Y
Biomaterials; 2024 Oct; 310():122625. PubMed ID: 38820768
[TBL] [Abstract][Full Text] [Related]
4. ATP-Responsive Manganese-Based Bacterial Materials Synergistically Activate the cGAS-STING Pathway for Tumor Immunotherapy.
Yang H; Yang S; Guo Q; Sheng J; Mao Z
Adv Mater; 2024 Jun; 36(23):e2310189. PubMed ID: 38414097
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy-sensitized cancer immunotherapy via cGAS-STING immune pathway by activatable nanocascade reaction.
Hu H; Zheng S; He C; Zheng Y; Wei Q; Chen S; Wu Z; Xu Y; Zhao B; Yan C
J Nanobiotechnology; 2024 May; 22(1):234. PubMed ID: 38724978
[TBL] [Abstract][Full Text] [Related]
6. Dual-Modality Imaging-Guided Manganese-Based Nanotransformer for Enhanced Gas-Photothermal Therapy Combined Immunotherapeutic Strategy Against Triple-Negative Breast Cancer.
Guan X; Zeng N; Zhao Y; Huang X; Lai S; Shen G; Zhang W; Wang N; Yao W; Guo Y; Yang R; Wang Z; Jiang X
Small; 2024 May; 20(22):e2307961. PubMed ID: 38126911
[TBL] [Abstract][Full Text] [Related]
7. Dual-Responsive Supramolecular Polymeric Nanomedicine for Self-Cascade Amplified Cancer Immunotherapy.
Hu W; Ye B; Yu G; Yang H; Wu H; Ding Y; Huang F; Wang W; Mao Z
Adv Sci (Weinh); 2024 May; 11(20):e2305382. PubMed ID: 38493499
[TBL] [Abstract][Full Text] [Related]
8. H
Wang W; Fu R; Gao R; Luo L; Wang Z; Xue Y; Sun J; Pan M; Hong M; Qiao L; Qiao W; Mei Q; Wu J; Wang Y; Zhong Y; Liu J; Tong F
ACS Biomater Sci Eng; 2024 Jun; 10(6):3994-4008. PubMed ID: 38736179
[TBL] [Abstract][Full Text] [Related]
9. Programmed Targeting Pyruvate Metabolism Therapy Amplified Single-Atom Nanozyme-Activated Pyroptosis for Immunotherapy.
Niu R; Liu Y; Xu B; Deng R; Zhou S; Cao Y; Li W; Zhang H; Zheng H; Song S; Wang Y; Zhang H
Adv Mater; 2024 Jun; 36(24):e2312124. PubMed ID: 38314930
[TBL] [Abstract][Full Text] [Related]
10. Spatiotemporal release of non-nucleotide STING agonist and AKT inhibitor from implantable 3D-printed scaffold for amplified cancer immunotherapy.
Wang H; Liu Z; Fang Y; Luo X; Zheng C; Xu Y; Zhou X; Yuan Q; Lv S; Ma L; Lao YH; Tao Y; Li M
Biomaterials; 2024 May; 311():122645. PubMed ID: 38850717
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactive Microenvironment Modulator GBP5 Suppresses Ovarian Cancer Progression by Inducing Canonical Pyroptosis.
Zou C; Shen J; Xu F; Ye Y; Wu Y; Xu S
J Cancer; 2024; 15(11):3510-3530. PubMed ID: 38817865
[TBL] [Abstract][Full Text] [Related]
12. Correction to: Near-Infrared Light-Triggered Thermoresponsive Pyroptosis System for Synergistic Tumor Immunotherapy.
Zhu G; Zheng P; Wang M; Xie Y; Sun Q; Gao M; Li C
Adv Healthc Mater; 2024 Jun; ():e2401670. PubMed ID: 38864532
[No Abstract] [Full Text] [Related]
13. Gas-Amplified Metalloimmunotherapy with Dual Activation of Pyroptosis and the STING Pathway for Remodeling the Immunosuppressive Cervical Cancer Microenvironment.
Liu L; Lei H; Hou G; Zhang L; Chen Y; Lu Y; Pei Z; Ge J; Wu J; Zhou J; Cheng L
ACS Nano; 2024 May; 18(20):12830-12844. PubMed ID: 38709246
[TBL] [Abstract][Full Text] [Related]
14. Smart responsive Fe/Mn nanovaccine triggers liver cancer immunotherapy via pyroptosis and pyroptosis-boosted cGAS-STING activation.
Du Q; Luo Y; Xu L; Du C; Zhang W; Xu J; Liu Y; Liu B; Chen S; Wang Y; Wang Z; Ran H; Wang J; Guo D
J Nanobiotechnology; 2024 Mar; 22(1):95. PubMed ID: 38448959
[TBL] [Abstract][Full Text] [Related]
15. Manganese molybdate nanodots with dual amplification of STING activation for "cycle" treatment of metalloimmunotherapy.
Lei H; Li Q; Li G; Wang T; Lv X; Pei Z; Gao X; Yang N; Gong F; Yang Y; Hou G; Chen M; Ji J; Liu Z; Cheng L
Bioact Mater; 2024 Jan; 31():53-62. PubMed ID: 37601278
[TBL] [Abstract][Full Text] [Related]
16. Metal coordination nanotheranostics mediated by nucleoside metabolic inhibitors potentiate STING pathway activation for cancer metalloimmunotherapy.
Yang L; Wang Y; Song Y; Li Z; Lei L; Li H; He B; Cao J; Gao H
J Control Release; 2024 Jun; 370():354-366. PubMed ID: 38685387
[TBL] [Abstract][Full Text] [Related]
17. Decomposable Nanoagonists Enable NIR-Elicited cGAS-STING Activation for Tandem-Amplified Photodynamic-Metalloimmunotherapy.
Guo X; Tu P; Wang X; Du C; Jiang W; Qiu X; Wang J; Chen L; Chen Y; Ren J
Adv Mater; 2024 May; 36(21):e2313029. PubMed ID: 38353366
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
